Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Pharmacologic profile of perphenazine's metabolites.

Sweet RA, Pollock BG, Mulsant BH, Rosen J, Sorisio D, Kirshner M, Henteleff R, DeMichele MA.

J Clin Psychopharmacol. 2000 Apr;20(2):181-7.

PMID:
10770456
2.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
3.
4.

Serotonin receptors: their key role in drugs to treat schizophrenia.

Meltzer HY, Li Z, Kaneda Y, Ichikawa J.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. Review.

PMID:
14642974
5.

Receptor mechanisms in the treatment of schizophrenia.

Reynolds GP.

J Psychopharmacol. 2004 Sep;18(3):340-5. Review.

PMID:
15358977
6.

[Which properties make a neuroleptic "atypical"?].

GrĂ¼nder G, Vernaleken I, Benkert O.

Nervenarzt. 2001 Nov;72(11):833-43. Review. German.

PMID:
11758090
7.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
8.

Neuropharmacological profile of an atypical antipsychotic, NRA0562.

Hirota S, Kawashima N, Chaki S, Okuyama S.

CNS Drug Rev. 2003 Winter;9(4):375-88. Review.

Supplemental Content

Support Center